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ABSTRACT
Alanine aminotransferase (ALT) and aspartate aminotransferase 
(AST) are found in the liver in their highest concentrations. Two 
most common causes of asymptomatic transaminase elevation 
are viral infections and alcohol intake. Persistent non-viral non-
alcohol related elevation of aminotransferases indicates that one 
or both aminotransferase levels exceed the upper reference limit 
for a period of at least 4 weeks. Causes are classified as hepatic; 
such as steatosis, autoimmune hepatitis, Wilson’s disease, 
hemachromatosis, and nonhepatic;  such as celiac disease, 
myopathy and hyperthyroidism. Drug use and substance abuse 
may also cause an increase in aminotransferase levels. Here, we 
report a fifty-eight-year old female patient who had asymptomatic 
non-viral non-alcohol related aminotransferase elevation for a year 
incidentally diagnosed with malignant infiltration of the liver. It 
should be noted that, malignant infiltration of the liver may also be 
a rare cause of asymptomatic persistent elevation of transaminases. 
Such cases, especially with suspected malignancy should be 
evaluated in terms of this condition.
Keywords: Aspartate aminotransferase, Alanine aminotransferase, 
Asymptomatic diseases, Incidental findings
ÖZ
Alanin aminotransferaz (ALT) ve aspartat aminotransferaz (AST) 
en yüksek konsantrasyonlarda karaciğerde bulunur. Asemptomatik 
transaminaz yüksekliğinin en sık iki sebebi viral enfeksiyonlar 
ve alkol kullanımıdır. Virüs ve alkol ilişkisi olmadan persistan 
aminotransferans yüksekliği, tanımlanır. Bu yüksekliğe,  steatoz, 
otoimmün hepatit, Wilson hastalığı, hemokromatoz gibi hepatik 
kaynaklı nedenler  ve çölyak hastalığı, miyopati ve hipertiroidizm 
gibi hepatik olmayan nedenler sebep olabilir.  İlaç kullanımı ve 
uyuşturucu madde kullanımı da aminotransferaz yüksekliğine sebep 
olabilir. Bu vakada elli sekiz yaşında kadın bir hasta sunmaktayız. 
Hastanın non-virüs non-alkol sebepli 1 yıl süren aminotransferaz 
yüksekliği mevcut olup hasta insidental olarak malin karaciğer 
infiltrasyonu tanısı almıştır. Karaciğerin malin infiltrasyonunun 
da persistan asemptomatik transaminaz yüksekliğine sebep 
olabileceği unutulmamalıdır. Bu tarz hastalarda, özellikle malinite 
şüphesi olan vakalar bu yönden de değerlendirilmelidir.
Anahtar kelimeler: Aspartat aminotransferaz, Alanin 
aminotransferaz, Asemptomatik hastalık, Rastlantısal bulgular
Introduction
Alanine aminotransferase (ALT) and aspartate 
aminotransferase (AST) enzymes  are found in the liver 
in their highest concentrations. Both enzymes are released 
when the liver cell membrane is damaged and ALT is more 
specific to liver injury [1].  Two most common causes of 
asymptomatic transaminase elevation are viral infections 
and alcohol intake [1]. Persistent non-virus non-alcohol 
related aminotransferase elevation indicates that one or both 
aminotransferase levels exceed the upper reference limit for 
at least 4 weeks. Prevalence of this condition in Italy and 
United States is around  3-5% [2]. Causes of persistent non-
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viral non-hepatic aminotransferase elevation is classified 
as hepatic causes, apart from alcohol intake and viral 
infections, such as steatosis, autoimmune hepatitis, Wilson’s 
disease, hemachromatosis; and nonhepatic causes such as 
celiac disease, myopathy and hyperthyroidism [1,3]. Drugs, 
substance abuse and herbs may also cause an increase in 
liver enzymes,  such as acetaminophen use [1,4]. However, 
a minor elevation of AST and ALT (less than twice the 
normal value) may be of no clinical importance and may 
not even be abnormal [1]. Here, we report a rare case of 
asymptomatic non-viral non-alcohol related liver enzyme 
elevation incidentally diagnosed with malignant infiltration 
of the liver.
Case Report
A fifty-eight-year old female patient who had asymptomatic 
AST and ALT elevation was referred to Gastroenterology 
outpatient clinic by her family physician. She was 
asymptomatic apart from mild occasional pain in her 
abdomen, arms and legs. Her family physician advised 
lifestyle modifications such as diet and exercise, however, 
significant improvement was not observed in one year. She 
had no drug or alcohol use. She had previously undergone total 
hysterectomy and bilateral oophorectomy due to excessive 
bleeding of  the uterine myomas. She states that her mother 
had undergone hysterectomy from a benign pathology, 
and two of her uncles passed away from lung carcinomas. 
Her physical examination was normal. Laboratory results 
were: Hemoglobin:9.7 g/dl, Mean Corpuscular Volume 
(MCV): 67 fL, leukocytes: 6510/mm3, neutrophils: 3660/
mm3, platelets: 279.000/mm3, ALT: 91 U/L AST: 66 U/L, 
gamma-glutamyl transpeptidase (GGT): 53 U/L, alkaline 
phosphatase (ALP): 111 U/L, lactate dehydrogenase (LDH): 
178 U/L, total bilirubin: 0.36 mg/dL  direct bilirubin: 
0.1 mg/dL, albumin: 4.27 g/dL PT: 11.8 seconds, aPTT: 
24.4 seconds, INR: 1.03, TSH: 1.06 uIU/ml, fT4: 1.04 
ng/dl and ferritin: 5.64 ng/ml. A work-up for persistent 
aminotransferase elevation was planned.  Hepatitis B and 
C, HIV, EBV, CMV and HSV serologies were negative. 
ANA was 1/100 weak granular positive, ENA assay was 
negative, ANCA, Anti-LKM and ASMA were negative as 
well. Plasma seruloplasmin, alpha-1 antitrypsin and 24-hour 
urinary copper excretion were within normal range. Anti-
endomysium IgA and IgG were both negative. Abdominal 
ultrasonography (USG) revealed a mild hepatomegaly with 
normal parencyhmal echo and no local masses. Hepatic 
Doppler USG was normal. 
A liver biopsy was carried out to diagnose the cause 
of persistent elevation of liver enzymes. Biopsy revealed 
malignant infiltration of liver with vimentin, CK7, 18 and 
19 positive cells (Figure 1). No primary focus was diagnosed 
from the biopsy. Pathology advised genitourinary check-up 
for primary tumor. Upper gastrointestinal endoscopy and 
colonoscopy were normal. Thorax and abdomen computed 
tomographies (CT) were normal. Gynecological examination, 
urological examination, mammography and breast ultrasound 
were normal. Carcinoembryogenic antigen, Ca 15-3, Ca19-
9 and CA125 were within normal range. Positron emission 
tomography (PET)-CT revealed metastatic focuses in hepatic 
segments 2 and 4 (SUVmax: 7), a focus on anterior wall of 
gallbladder (SUVmax: 6), periportal hypermetabolic lymph 
nodes (SUVmax: 6), a focus on distal choledochus (SUVmax: 
6) and multiple gastric and duodenal focuses (SUVmax: 8) 
(Figure 2). Patient was diagnosed as metastatic malignant 
epithelial tumor with unknown primary origin and was 
referred to Oncology Department. Carboplatin-paclitaxel 
chemotherapy was planned. 
Figure 1: (a) Serial sections from tissue specimens reveal liver 
(bottom right) in the vicinity of tumor tissue (top left) (H&E, x200) 
(b) High magnification of tumor shows it is composed of trabecule 
and gland forming atypical cells (H&E, x400)
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Figure 2: Metastatic focuses in hepatic segments 2 and 4 
(SUVmax: 7), a focus on anterior wall of gallbladder (SUVmax: 
6, reported as primary?, metastatis?), periportal hypermetabolic 
lymph nodes (SUVmax: 6, reported as metastasis?), a focus on 
distal choledochus (SUVmax: 6, reported as malignancy?) and 
multiple gastric and duodenal focuses (SUVmax: 8) can be seen 
on PET-CT.
Discussion
Asymptomatic non-virus non-alcohol related liver enzyme 
elevation is a very common clinical picture. Rochling 
[5] reported that 6% of asymptomatic people may have 
abnormal liver enzyme levels whereas overall prevalence 
of liver disease is only 1%. Giboney [3] states up to 4% of 
the asymptomatic population may have elevated serum liver 
tests. A follow up study on patients who had mild elevation 
of liver enzymes showed 38% spontaneous remission [6]. 
These findings state that not all asymptomatic liver enzyme 
elevations are pathologic. Apart from alcohol intake and 
viral infections, steatosis and medications are common 
causes of asymptomatic transaminase elevation, whereas 
hemochromatosis, autoimmune hepatitis, Wilson’s disease 
and Celiac’s disease may cause asymptomatic transaminase 
elevations as well [1,3]. Drugs such as synthetic penicillins, 
ciprofloxacin, phenytoin, carbamazepine, non-steroidal anti-
inflammatory drugs and acetaminophen  may cause mild 
elevations of transaminases [1, 4]. Some herbs and substances 
of abuse may also cause elevation of transaminases, however 
our patient did not use such substances. 
The adapted form of American Gastroenterological 
Association (AGA) statement by Giboney [3] suggests that 
if a patient has less than five times elevated transaminases, 
first line tests should be prothrombin time, albumin, complete 
blood count, hepatitis A, B, and C serologies, serum iron, 
total iron binding capacity and ferritin. Patients with 
negative serologies and without hepatic decompensation 
should modify their lifestyles: discontinue alcohol use, 
stop taking hepatotoxic medications and lose weight. If 
aminotransferase levels are still elevated at the six month 
follow up, further testing of antinuclear antibodies, anti–
smooth-muscle antibody, ceruloplasmin, alpha 1-antitrypsin, 
antigliadin, and antiendomysial antibody for rare causes of 
aminotransferase elevation are warranted. According to the 
AGA, decision to perform a liver biopsy needs to be made 
on an individual basis, taking into consideration the patient’s 
age, lifestyle, liver chemistry abnormalities, desire for 
prognostic information, and associated comorbid conditions 
[7, 8]. Our patient had all first line tests, she tried life style 
modification without success and then was referred to our 
clinic. Further tests were also negative and a liver biopsy 
was carried out on patient’s consent.
Liver biopsy may not change the prognosis or diagnosis 
in these patients. A study of 149 asymptomatic patients with 
elevated ALT levels who underwent liver biopsy showed 
56%  of these patients had fatty liver disease, 20%  had non-
viral hepatitis (non-A, non-B), 11%  had changes related to 
alcohol use, 3%  had hepatitis B, 8%  had other causes, and 
in 2% , no cause was identified [9].  Another study assessed 
1124 consecutive patients who were referred for chronic 
elevations in aminotransferase levels. Eighty-one of these 
patients had no definable cause and underwent liver biopsies. 
Out of these 81, 41 had steatosis, 26 had steatohepatitis, 4 
had fibrosis, 2 had cirrhosis and 8 had normal histological 
findings. Patients with histological evidence of fibrosis and 
cirrhosis also had evidence of fatty metamorphosis. None 
of the biopsies yielded a specific diagnosis except showing 
steatosis and steatohepatitis [10].
We present a patient who had asymptomatic mild 
elevation of transaminases over a year. After most common 
pathologies were ruled out, a liver biopsy was carried out. 
Although current literature states that liver biopsy almost 
always does not yield any specific diagnosis and does not 
change prognosis in these patients, our biopsy showed 
malignant infiltration of the liver. USG and CT of the 
abdomen failed to detect liver involvement while PET-
CT revealed metastatic focuses in our case. It is not clear 
that, whether the liver biopsy was taken incidentally from 
metastatic focuses, which were detected on  PET-CT, or 
there was a diffuse involvement in the liver. We did not 
perform a repeat biopsy. 
Radiologically occult liver metastasis usually occurs 
as diffuse malignant infiltration of the liver. This has been 
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reported in the literature secondary to metastases from breast 
and lung carcinomas, prostate and urothelial carciomas, 
carcinomas of unknown primary origin and hematologic 
malignancies such as Hodgkin and Non-Hodgkin 
lymphomas [11-16]. USG and CT scans of the liver were 
reported as normal in almost all of these reported cases as 
it was in our case. Although,  PET-CT revealed a suspected 
primary focus in gallbladder and gastric focuses in our 
case, urological and endoscopic examinations were normal 
and we could not  find a clear primary origin. In addition, 
most of the reported cases presented with fulminant hepatic 
failure and showed poor prognosis, however, our case was 
asymptomatic and manifested with chronic persistent mild 
elevation of transaminases.
In conclusion, it should be noted that, malignant 
infiltration of the liver may also be a rare cause of persistent 
asymptomatic mild elevation of transaminases. Such cases, 
especially with suspected malignancy symptoms, should be 
thoroughly evaluated in terms of this condition. 
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